OCT 07, 2019 2:05 PM PDT

It's not all bad: cancer and aging

Research published recently in the journal Aging Cell highlights the complexities of the interactions that occur during the aging process from the angle of how it relates to cancer. Surprisingly, the findings report that although aging is one of the greatest risks for cancer, the natural process of senescence that cells go through as they age may actually deter cancer cells’ development.

Senescence refers to the progression of cells’ lives when they become dormant and stop growing, dividing, and renewing. It has long been thought that aging senescent cells have a higher probability of turning cancerous because of an accumulation of multiple mutations in cancer causing-genes. Yet, by definition itself, senescence is the opposite process of cancer: the cease of dividing cells versus the uncontrollable division and growth of cells.

"You have these two opposite forces: mutations driving cancer and tissue degeneration hindering it,” explains lead author Professor João Pedro de Magalhães from the University of Liverpool in the UK.

understand more about the role that senescence plays in cancer, the research team analyzed the genes that have been observed in the cancer progression of nine different human tissues. They wanted to determine their state of activity/non-activity, in order to see how the cells were behaving under certain age conditions.

New research exposes how senescence hinders cancer progression. Photo: Pixabay

What they observed was that for all the tissues they analyzed except those from the thyroid and the uterus, aging and cancer gene activity patterns changed in opposite directions – which is to say that some aging genes were more active while some cancer genes were less active. Thyroid and uterine tissues were the exceptions to this trend, with both aging genes and cancer genes changing in the same direction.

These findings dig deeper into the complexities of aging and cancer and could potentially explain why although older people are at a higher risk of developing cancer, the incidence of cancer also levels off toward the end of life. The researchers say that though this is a good start, much more investigation will be needed in order to fully understand all the inner workings between these interactions.

Sources: Aging CellMedical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 02, 2020
Cancer
APR 02, 2020
Diagnosing Cancer: SMOC2 and Thyroid Cancer
  Thyroid cancer is the most common of the endocrine cancers, with papillary thyroid carcinomas (PTCs) being the mo ...
APR 12, 2020
Cancer
APR 12, 2020
Understanding the link between obesity and breast cancer
A researcher from the James Graham Brown Cancer Center at the University of Louisville claims to have figured out the mo ...
MAY 14, 2020
Cancer
MAY 14, 2020
New hope for immunotherapy for pediatric brain cancer
Pediatric brain cancer is an especially tough pill to swallow. While one in four children does not survive medulloblasto ...
MAY 10, 2020
Drug Discovery & Development
MAY 10, 2020
Antiviral Drug Treats Naso-Pharyngeal Cancer
Scientists at Hong Kong Baptist University (HKBU) developed a novel anti-Epstein-Barr virus (EBV) drug that can shrink t ...
MAY 30, 2020
Cancer
MAY 30, 2020
Linking an Aggressive Tumor Factor to the Innate Immune Response
Epithelial Ovarian Cancer (EOC) is a cancer of the fallopian tubes with a low five-year survival rate with a tendency to ...
JUN 01, 2020
Cancer
JUN 01, 2020
A New RNA in Fine-Tuned Signal Regulation
In a healthy cell, many complex networks work to make sure everything runs as it should. Some of these networks function ...
Loading Comments...